Showing papers by "Zeev Rosberger published in 2021"
TL;DR: A mixed-methods systematic review using a results-based convergent design to provide the first comprehensive overview of emotional response to testing positive for HPV (HPV+) revealed that testing HPV+ was related to disgust/shame, surprise and fear about cancer.
Abstract: Tens-of-millions of women every year test positive for human papillomavirus (HPV) at routine cervical screening. We performed a mixed-methods systematic review using a results-based convergent desi...
34 citations
TL;DR: The forum reduced loneliness and allowed participants to learn new ways to manage stress and was particularly beneficial for those with heightened psychological distress.
Abstract: Feelings of loss, shame and stigmatization, reduced quality of life, isolation and loneliness are common among men and women with infertility. Fertility patients may seek peer mentoring and support...
12 citations
TL;DR: In this article, a mobile health applicator for men to become fathers is presented to increase men's awareness of infertility risk factors, which is a public health concern in the United States.
Abstract: Male infertility presents a public health concern. As most men wish to become fathers, it is important to increase men’s awareness of infertility risk factors. We developed a mobile health applicat...
6 citations
TL;DR: In this paper, the authors discuss global cancer control within Canada's global health agenda, how Canada can address its history of colonisation and present-day disparities in its global work, and the challenges and opportunities of creating a Canadian global cancer network.
Abstract: Cancer has not been an explicit priority of Canada's international health and development agenda, but it is key to realising the country's Sustainable Development Goal commitments. Multiple converging political, health, and social forces could now drive support for a more integrated Canadian approach to global cancer control. Success will depend on the extent to which Canadian leaders and institutions can build consensus as a community and agree to work together. Collaboration should include agreement on the framing and prioritisation of the core issues, building a broad coalition base, aligning with priorities of international partners, and on a governance structure that reflects the principles of equity, diversity, and inclusion. This Series paper will discuss global cancer control within Canada's global health agenda, how Canada can address its history of colonisation and present-day disparities in its global work, and the challenges and opportunities of creating a Canadian global cancer control network.
4 citations
3 citations
01 Feb 2021
TL;DR: The epidemiology and public health burden of cervical cancers is outlined, with emphasis on the two most populous countries of India and China, and HPV vaccine–related successes and challenges in low- and middle- Income countries contrasted with high-income countries are described.
Abstract: Cervical cancer kills 300,000 women annually, despite being among the most preventable of all cancers, with a well-known cause (human papilloma virus [HPV]), established and successful screening strategies, and effective vaccination and treatments. This chapter examines the reasons for this inconsistency and begins by outlining the epidemiology and public health burden of cervical cancers. It describes HPV vaccine–related successes and challenges in low- and middle-income countries contrasted with high-income countries, with emphasis on the two most populous countries of India and China, before examining issues around strategies for cervical cancer screening in high- and low-resource settings. Following discussion of screening recommendations, the chapter describes barriers and facilitators to vaccination, screening, and testing. It then addresses screening and vaccination messaging and the psychological impact of testing and concludes with future directions.
1 citations
TL;DR: In this article, the authors determined the contribution of pre-cancer psychosocial vulnerability as an independent predictor of anxiety disorder onset immediately post-treatment in patients diagnosed with a first occurrence of head and neck cancer, controlling for sociodemographics and medical variables.
Abstract: Objective This study aimed to: 1) determine the contribution of pre-cancer psychosocial vulnerability as an independent predictor of Anxiety Disorder (AD) onset immediately post-treatment in patients diagnosed with a first occurrence of head and neck cancer, controlling for sociodemographics and medical variables; and 2) estimate prevalence of AD and identify trajectories from the moment of diagnosis to the immediate post-treatment (i.e., over a period of three months) in this population. Methods 224 consecutive patients (participation rate = 72%) newly diagnosed with a primary HNC were assessed with a structured clinical interview for a mental disorder, validated psychometric measures, and medical chart reviews. Results Twenty-five percent of patients presented a lifetime AD, 19.4% within 2 weeks of HNC diagnosis, and 16.6% immediately post-treatment; representing 26.7% of patients with AD at any timepoint from the moment of diagnosis to immediately post-treatment. Patients were more likely to present an AD immediately post-treatment when they: were diagnosed with advanced-stage cancer (O.R.=3.40, , p=0.006), presented a upon cancer diagnosis AD (O.R.=2.45, p=0.008) and/or experienced childhood abuse (O.R.=1.96, p=0.03). Conclusions Several AD trajectories may arise when patients are diagnosed with primary HNC. Health professionals should address AD and screen for risk factors (i.e., advanced stage cancer, AD upon cancer diagnosis, history of childhood abuse) as early as possible to assure optimal mental health care in this vulnerable population. This article is protected by copyright. All rights reserved.
1 citations